David E. Newcomb

1.5k total citations
14 papers, 1.3k citations indexed

About

David E. Newcomb is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, David E. Newcomb has authored 14 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 5 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in David E. Newcomb's work include Immune Response and Inflammation (9 papers), Sepsis Diagnosis and Treatment (5 papers) and Chemokine receptors and signaling (4 papers). David E. Newcomb is often cited by papers focused on Immune Response and Inflammation (9 papers), Sepsis Diagnosis and Treatment (5 papers) and Chemokine receptors and signaling (4 papers). David E. Newcomb collaborates with scholars based in United States and United Kingdom. David E. Newcomb's co-authors include Daniel G. Remick, G. Bolgos, Douglas R. Call, Samuel Ebong, Jean A. Nemzek, Gordon K. Wollenberg, Sunir J. Garg, Jill Granger, Michael O’Reilly and Jon S. Friedland and has published in prestigious journals such as Critical Care Medicine, American Journal Of Pathology and Infection and Immunity.

In The Last Decade

David E. Newcomb

14 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David E. Newcomb United States	11	725	483	221	183	179	14	1.3k
F. Ulrich Schade Germany	21	648 0.9×	435 0.9×	242 1.1×	155 0.8×	139 0.8×	34	1.3k
Y Vrindts Belgium	7	402 0.6×	386 0.8×	249 1.1×	130 0.7×	123 0.7×	11	1.1k
Valérie Faivre France	21	563 0.8×	624 1.3×	321 1.5×	190 1.0×	199 1.1×	45	1.5k
Craig S. Rock United States	9	654 0.9×	450 0.9×	343 1.6×	154 0.8×	94 0.5×	10	1.6k
K Inada Japan	21	437 0.6×	452 0.9×	247 1.1×	173 0.9×	119 0.7×	68	1.2k
Mohammed M. Sayeed United States	23	481 0.7×	411 0.9×	438 2.0×	80 0.4×	120 0.7×	60	1.4k
Richard A. Winchurch United States	23	444 0.6×	370 0.8×	292 1.3×	99 0.5×	110 0.6×	51	1.3k
Brian A. Nadeau United States	12	673 0.9×	312 0.6×	327 1.5×	146 0.8×	78 0.4×	18	1.4k
Eline Dejonckheere Belgium	9	369 0.5×	289 0.6×	334 1.5×	136 0.7×	99 0.6×	11	1.2k
Naoyuki Hashiguchi Japan	19	491 0.7×	274 0.6×	426 1.9×	226 1.2×	359 2.0×	33	1.7k

Countries citing papers authored by David E. Newcomb

Since Specialization

Citations

This map shows the geographic impact of David E. Newcomb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Newcomb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Newcomb more than expected).

Fields of papers citing papers by David E. Newcomb

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Newcomb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Newcomb. The network helps show where David E. Newcomb may publish in the future.

Co-authorship network of co-authors of David E. Newcomb

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Newcomb. A scholar is included among the top collaborators of David E. Newcomb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Newcomb. David E. Newcomb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Remick, Daniel G., David E. Newcomb, & Jon S. Friedland. (2003). Whole-Blood Assays for Cytokine Production. Humana Press eBooks. 36. 101–112. 7 indexed citations

Wang, Xian, et al.. (2002). Calcitonin Gene-Related Peptide Partially Reverses Decreased Production of Chemokines KC and MIP-2 Following Murine Sepsis. Inflammation. 26(4). 167–174. 10 indexed citations

Call, Douglas R., Jean A. Nemzek, Samuel Ebong, et al.. (2001). DIFFERENTIAL LOCAL AND SYSTEMIC REGULATION OF THE MURINE CHEMOKINES KC AND MIP2. Shock. 15(4). 278–284. 77 indexed citations

Call, Douglas R., Jean A. Nemzek, Samuel Ebong, et al.. (2001). Ratio of Local to Systemic Chemokine Concentrations Regulates Neutrophil Recruitment. American Journal Of Pathology. 158(2). 715–721. 90 indexed citations

Remick, Daniel G., et al.. (2001). Combination immunotherapy with soluble tumor necrosis factor receptors plus interleukin 1 receptor antagonist decreases sepsis mortality. Critical Care Medicine. 29(3). 473–481. 62 indexed citations

Remick, Daniel G., et al.. (2001). CXC Chemokine Redundancy Ensures Local Neutrophil Recruitment during Acute Inflammation. American Journal Of Pathology. 159(3). 1149–1157. 57 indexed citations

Remick, Daniel G., David E. Newcomb, G. Bolgos, & Douglas R. Call. (2000). COMPARISON OF THE MORTALITY AND INFLAMMATORY RESPONSE OF TWO MODELS OF SEPSIS: LIPOPOLYSACCHARIDE VS. CECAL LIGATION AND PUNCTURE. Shock. 13(2). 110–116. 439 indexed citations

Nemzek, Jean A., Douglas R. Call, Samuel Ebong, et al.. (2000). Immunopathology of a two-hit murine model of acid aspiration lung injury. American Journal of Physiology-Lung Cellular and Molecular Physiology. 278(3). L512–L520. 43 indexed citations

Newcomb, David E., et al.. (1999). ENDOTOXIN, SEPSIS, AND THE PRIMROSE PATH. Shock. 12(6). 411–420. 67 indexed citations

10.

Ebong, Samuel, Douglas R. Call, G. Bolgos, et al.. (1999). IMMUNOPATHOLOGIC RESPONSES TO NON-LETHAL SEPSIS. Shock. 12(2). 118–126. 86 indexed citations

11.

Nemzek, Jean A., David E. Newcomb, Douglas R. Call, & Daniel G. Remick. (1999). Plasma Interference in an Enzyme-Linked Immunosorbant Assay Using a Commercial Matched Antibody Pair. Immunological Investigations. 28(4). 209–221. 5 indexed citations

12.

Ebong, Samuel, Douglas R. Call, Jean A. Nemzek, et al.. (1999). Immunopathologic Alterations in Murine Models of Sepsis of Increasing Severity. Infection and Immunity. 67(12). 6603–6610. 188 indexed citations

13.

Remick, Daniel G., et al.. (1998). Exogenous interleukin-10 fails to decrease the mortality or morbidity of sepsis. Critical Care Medicine. 26(5). 895–904. 75 indexed citations

14.

Newcomb, David E., et al.. (1998). ANTIBIOTIC TREATMENT INFLUENCES OUTCOME IN MURINE SEPSIS. Shock. 10(2). 110–117. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact